A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far ...

InflaRx cofounder and CEO Niels Riedemann, M.D. shares the overarching pillars that have shaped his career as a physician, ...

With just the click of a button on your smartphone, you can order virtually anything and have it on your doorstep in one or ...

Growth hormone deficiency (GHD) is a rare disorder characterized by the insufficient production of growth hormone, which is essential for stimulating the growth of bones and other tissues. Children ...

Barinthus Biotherapeutics is currently working on therapeutics for HPV and celiac disease, two disease areas that are projected to grow rapidly.

Disease progression in metastatic breast cancer is a challenge that no single entity can solve alone. Breakthroughs in ...

In the world of biopharmaceutical innovation, groundbreaking scientific discoveries often do not directly translate into commercial success. Simply developing a promising therapeutic based on great ...

Even in the best funding environments, raising money for drug discovery is an enormous challenge. It takes about 10 years and upwards of a billion dollars to move a drug candidate from the lab through ...

No drug is free from risks, and no two human anatomies are completely identical (meaning different individuals can face different risks), but from a real-world patient perspective — anecdotally — the ...